MRVL vs RGEN · P/E 100, rev $5.16B vs P/E 143, rev $204.1M
Marvell Technology Group Ltd (MRVL) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the MRVL and RGEN stock pages for the full models.
Not investment advice.